CD4+ tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts
A. Jimenez-Reinoso, M. Molero-Abraham, C. Cirauqui, B. Blanco, E. M. Garrido-Martin, D. Nehme-Alvarez, C. Dominguez-Alonso, A. Ramirez-Fernandez, L. Diez-Alonso, A. Nunez-Buiza, A. Gonzalez-Murillo, R. Tobes, E. Pareja, M. Ramirez-Orellana, J. L. Rodriguez-Peralto, , L. Alvarez-Vallina
This study shows that engineered CD4+ TIL secreting TCE can induce tumor regression in NSCLC PDX models by redirecting non-tumor dominant T cell clones.
bioRxiv · May 27, 2024Cancer Biology